You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
11/09/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
11 |
10/31/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
6 |
10/04/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
1 | |
10/04/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
1 | |
08/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
76 |
08/10/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
10 |
07/22/22 | S-8 POS | Post-effective amendment to a S-8 registration statement |
![]() |
9 | |
07/22/22 | S-8 POS | Post-effective amendment to a S-8 registration statement |
![]() |
9 | |
07/22/22 | S-8 POS | Post-effective amendment to a S-8 registration statement |
![]() |
9 | |
07/22/22 | S-8 POS | Post-effective amendment to a S-8 registration statement |
![]() |
9 |